Section
Money
Earnings analysis, pricing strategy, and financial dynamics
MoneyEndpoints News ↗
CSL's stock hit its lowest price since early 2017 on Monday after it lowered its full-year revenue guidance by…
MoneyBioPharma Dive ↗
The Indianapolis-based company expanded its spend to ensure it can meet growing demand for its weight-loss dru…
MoneyBriefing
The oral Wegovy launch brought $355M in its first quarter, helping Novo beat consensus despite insulin softnes…
MoneyEndpoints News ↗
Odyssey Therapeutics pulled together $279 million from its initial public offering, the autoimmune disease dru…
MoneyBioPharma Dive ↗
Even though Elevidys beat Wall Street expectations, analysts expect investor focus to shift toward Sarepta's e…
MoneyPharmaVoice ↗
Sales and profit should shrink less than originally anticipated thanks to strong momentum for its new obesity …
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.